Abstract:Objectives: Patients with acute exacerbation of chronic obstructive pulmonary disease (AECOPD) combined with severe type II respiratory failure have a high probability of ventilation failure using conventional non-invasive positive pressure ventilation (NPPV). This study aims to investigate the clinical efficacy of high intensity NPPV (HI-NPPV) for the treatment of AECOPD combined with severe type II respiratory failure. Methods: The data of patients with AECOPD combined with severe type II respiratory failure (blood gas analysis pH≤7.25) treated with NPPV in the Second Affiliated Hospital of Chongqing Medical University from July 2013 to July 2023 were collected to conduct a retrospective case-control study. The patients were divided into 2 groups according to the inspired positive airway pressure (IPAP) used during the NPPV treatment: a NPPV group (IPAP<20 cmH2O, 1 cmH2O=0.098 kPa) and a HI-NPPV group (20 cmH2O≤IPAP< 30 cmH2O). Ninety-nine and 95 patients were included in the NPPV group and the HI-NPPV group, respectively. A total of 86 pairs of data were matched using propensity score matching (PSM) for data matching. The primary outcome indexes (mortality and tracheal intubation rate) and secondary outcome indexes [blood gas analysis pH, arterial partial pressure of oxygen (PaO2) and arterial partial pressure of carbon dioxide (PaCO2), adverse reaction rate, and length of hospitalization] were compared between the 2 groups. Results: The tracheal intubation rates of the NPPV group and the HI-NPPV group were 6.98% and 1.16%, respectively, and the difference between the 2 groups was statistically significant (χ2=4.32, P<0.05); the mortality of the NPPV group and the HI-NPPV group was 23.26% and 9.30%, respectively, and the difference between the 2 groups was statistically significant (χ2=11.64, P<0.01). The PaO2 at 24 h and 48 h after treatment of the HI-NPPV group was higher than that of the NPPV group, and the PaCO2 of the HI-NPPV group was lower than that of the NPPV group, and the differences were statistically significant (all P<0.05). The differences of pH at 24 h and 48 h after treatment between the 2 groups were not statistically significant (both P>0.05). The differences between the 2 groups in adverse reaction rate and hospitalization length were not statistically significant (both P>0.05). Conclusions: HI-NPPV can reduce mortality and tracheal intubation rates by rapidly improving the ventilation of patients with AECOPD combined with severe type II respiratory failure. This study provides a new idea for the treatment of patients with AECOPD combined with severe type II respiratory failure.

Noninvasive positive pressure ventilation in the treatment of cardiothoracic patients with acute respiratory failure

Evaluation of the Effectivenesss of Noninvasive Positive Pressure Ventilation As a Weaning Strategy in Patients with Acute Respiratory Failure

Application of Noninvasive Positive-Pressure Ventilation in Patients With Acute Respiratory Failure After Cardiopulmonary Bypass Surgery

Comparative Study of Pressure-Control Ventilation and Volume-Control Ventilation in Treating Traumatic Acute Respiratory Distress Syndrome.

The Comparison Between the Continual Positive Airway Pressure Ventilation and the Bilevel Positive Airway Pressure Ventilation in Treating Acute Cardiogenic Pulmonary Edema

An observation of noninvasive positive-pressure ventilation after cardiac surgery

The use of noninvasive ventilation in the treatment of acute cardiogenic pulmonary edema

Treatment of acute respiratory failure after extubation with noninvasive positive pressure ventilation

Airway Pressure Release Ventilation Mode Improves Circulatory and Respiratory Function in Patients after Cardiopulmonary Bypass, a Randomized Trial

The clinic study of Non-invasive positive pressure ventilation (NIPPV) on 63 cases with typeⅠ respiratory failure

[Acute Respiratory Failure and Noninvasive Positive Pressure Ventilation Treatment in Patients with Severe Acute Respiratory Syndrome].

Non-invasive positive pressure ventilation for patients with lung injury or acute respiratory distress syndrome after esophagectomy

Efficacy of noninvasive positive pressure ventilation in the treatment of acute bronchial asthma with respiratory failure

Clinical efficacy of HI-NPPV in the treatment of AECOPD combined with severe type II respiratory failure

Influencing factors of noninvasive positive pressure ventilation in the treatment of respiratory failure: a 10-year study in one single center

Noninvasive Positive Pressure Ventilation Treatment for Acute Respiratory Failure in SARS

[Prospective Randomized Controlled Clinical Study of Early Use of Noninvasive Positive Pressure Ventilation in the Treatment for Acute Exacerbation of Chronic Obstructive Pulmonary Disease].

The application Of noninvasive positive pressure ventilation in children with congenital heart disease after operation

Influence on cardiac - pulmonary function of acute respiratory failure patients by airway pressure release ventilation and intermittent positive pressure ventilation modes

Noninvasive positive pressure ventilation in patients with respiratory failure due to severe acute pancreatitis

Noninvasive Ventilation on Mortality of Acute Respiratory Distress Syndrome.